1. Home
  2. AVIR
  3. AVIR News

Latest Atea Pharmaceuticals Inc. (AVIR) News on May 25, 2024

Atea Pharmaceuticals Presents New Data Showcasing Potential Best-in-Class Combination Profile of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus at EASL Congress 2024

GlobeNewswire

3 days ago

Atea Pharmaceuticals Presents New Data Showcasing Potential Best-in-Class Combination Profile of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus at EASL Congress 2024

Thomson Reuters StreetEvents

7 months ago

Q3 2023 Atea Pharmaceuticals Inc Earnings Call

Share on Social Networks: